openPR Logo
Press release

Global Leukemia Market Report - Forecasts to 2026

Global Leukemia Market

Global Leukemia Market

The findings reviewed by GME stated that the Global Leukemia Market will expand at a CAGR value of 6.52% to reach USD 19.52 billion by 2026 from USD 13.21 billion by 2021. The factors supporting the leukemia market growth are the rising incidence of acute & chronic myeloid leukemia, rising research and developmental activities to launch non-invasive and advanced therapeutics for cancer treatment, increasing government expenditure on healthcare infrastructure and growing government initiatives for cancer awareness.

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Leukemia Market” - Forecast to 2026” https://www.globalmarketestimates.com/market-report/leukemia-market-3371

By Type (Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia), By Treatment Type (Chemotherapy, Targeted Drugs & Immunotherapy), By Molecule Type (Biologics, Small Molecules), By Mode of Administration (Oral Mode, Injectable Mode), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis
Key Market Insights:
• The targeted drugs segment will be the largest shareholder of the market owing to the increasing demand for targeted drugs. As compared to chemotherapy, targeted medications are the most extensively utilized as they have fewer side effects and a greater efficacy and success rate.
• The chemotherapy segment will be the fastest-growing segment with the highest CAGR value from 2021 to 2026 due to rising cases of leukemia.
• Rising investments in research & innovation activities, growing disposable income, and increasing awareness of leukemia will impact the leukemia cancer market trends positively in the APAC region
• F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, AbbVie, Inc., Sanofi, Amgen, Gilead Sciences, Celgene Corporation, Pfizer, Inc., Novartis AG, and Takeda Pharmaceutical Company Limited, among others are some of the key players in the market.
• In January 2019, Amgen announced that it bagged the European Commission (EC) approval for BLINCYTO monotherapy. This helped the company expand its product portfolio and enhance its presence in the global leukemia market

Browse the Report @ https://www.globalmarketestimates.com/market-report/leukemia-market-3371

Based on Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Acute Lymphocytic Leukemia
• Acute Myeloid Leukemia

Based on Treatment Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Chemotherapy
• Targeted Drugs & Immunotherapy

Based on Molecule Type Outlook (Revenue, USD Billion, 2021 - 2026)
• Small Molecule
• Biologics

Based on Mode of Administration Outlook (Revenue, USD Billion, 2021 - 2026)
• Oral Mode
• Injectable Mode

Regional Outlook (Revenue, USD Billion, 2021 – 2026)
• North America
• The U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
• Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
• Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Leukemia Market Report - Forecasts to 2026 here

News-ID: 2327216 • Views: 223

More Releases from Global Market Estimates Research & Consultants

Global Microgreens Market Size - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Microgreens Market is projected to grow from USD 1.35 billion in 2021 and is expected to reach USD 3.05 billion by 2026 at a CAGR of 10.5%. The rising use of innovative vertical and indoor farming techniques for farming, as well as increasing awareness regarding the potential of these techniques to resist infection are boosting growth. Browse
Global Mesoporous Silica Market Size-Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Mesoporous Silica Market is projected to grow from USD 165.0 million in 2021 and is expected to reach USD 259.7 million by 2026 at a CAGR of 9.5% from 2021 to 2026. Rising demand for mesoporous silica for drug discovery process, and increasing prevalence of chronic disorders are the major factors driving the growth of the
Portable Dialysis Machines Market Size-Forecasts to 2026
The global portable dialysis machines market is projected to grow from USD 16.1 billion in 2021 and is expected to reach USD 22.1 billion by 2026 at a CAGR of 6.5% from 2021 to 2026. The continuous need to optimize treatment plans while lowering its effect on quality of life, prioritizing minimally invasive methods, as well as international health breakthroughs and innovation, are some of the growth factors supporting the
Global Radome Market Size-Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Radome Market is projected to grow from USD 1.6 billion in 2021 to USD 3.1 billion by 2026 at a CAGR value of 15.2% between 2021 to 2026. The growing number of antenna installments for surveillance and communication, advancements in material technology, and growing investment in military and defense applications are expected to be the major

All 5 Releases


More Releases for Leukemia

Global Leukemia Therapeutics Market Continued Growth Report
The “Global Leukemia Therapeutics Market Continued Growth Report” Latest added Leukemia Therapeutics Market research study by Zion Market Research offers detailed product outlook and elaborates market review till 2026. , The Leukemia Therapeutics Market is the most blooming and promising sector of the industry. This overall Leukemia Therapeutics Market has been ascending at a higher rate with the enhancement of inventive strategies and a raising customer tendency. The wide-coming to
Juvenile Myelomonocytic Leukemia Therapeutics- Pipeline Analysis 2018
Juvenile myelomonocytic leukemia is a rare disease that occurs mostly in the children who are under four years of age. The abnormal growth of the monocytes results in the accumulation of monocytes in the bone marrow. Download the sample report @ https://www.pharmaproff.com/request-sample/1116 This leads to improper functioning of the bone marrow. The actual cause of juvenile myelomonocytic leukemia is still unknown; however, mutation in the RAS gene is observed in patients
Acute Myeloid Leukemia Market Growth by 2021
Acute Myeloid Leukemia (AML) is classed as an orphans disease. AML is a rare but a severe disease and is a most common leukemia. It is primarily a disease of the elderly, with an average age of diagnosis of approximately 66. AML results from the acquired changes in the DNA of a developing marrow cell. The marrow cells get converted into the leukemic cells, multiplies into 11 billion or more.
Acute Leukemia Therapeutics Pipeline Analysis
Acute leukemia is also known as cancer of blood cells in which immature blood cells modify into cancer cells. The disease arises from bone marrow and causes formation of numerous large blood cells. Leukemia is categorized into five different types namely acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, and hairy cell leukemia. Leukemia can produce be symptoms such as fever, recurrent nosebleeds, bone pain, swollen
Leukemia Therapeutics Market – Global Industry Insights, 2025
Leukemia is a cancer of blood cells and therefore, are occasionally referred to as ‘blood cancer’. Most blood cells are formed in the bone marrow. In leukemia, undeveloped blood cells become cancer. Leukemia can be either acute or chronic. Acute leukemia is a fast growing cancer, which usually gets worse rapidly. Chronic leukemia is a slow growing cancer, which gets worse slowly over time period. The treatment and diagnosis of
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo several stressful therapeutic interventions. If chemotherapy is not effective, stem cell transplantation mostly is the last chance for healing. However, a sudden graft rejection or disease relapse can always occur despite the successful transfer of the hematopoietic stem cells from donor to recipient. Therefore, the regular quantitative assessment of the donor and recipient cell-portion in the blood